Investment spending in the drug delivery sector has dropped significantly for the third quarter, but is staying ahead of last years numbers for the first through third quarters, according to a new report. Venture capital investments fell a significant 61.8% to $29.6 million during the three months ended September 30, though deal volume stayed the […]
Report: Medical device deal volume, spend down during Q3
Investors spent less money on fewer deals in the medical device sector during the third quarter and so far this year, bucking the overall growth trend for venture capital-backed firms, according to a new report. Venture capital investment fell -19.7% to $772.7 million during the three months ended Sept. 30, with deal volume down -20.3% […]
Report: Q3 2017 Healthcare VC funding steady, digital health deals drop
Venture Capital funding in the healthcare sector during the third quarter of 2017 stayed mostly in line with the previous quarter while digital health deals saw a significant drop, according to a PricewaterhouseCoopers and CB Insights MoneyTree report. VC funding during the third quarter of 2017 was directly in line with the previous quarter, but […]
Report: Q2 med device VC funding, deals down from Q1
Venture capital funding during the 2nd quarter was down from Q1, according to a PricewaterhouseCoopers and CB Insights MoneyTree report released last week. Funding in the life sciences industry was down from the 1st quarter at 147 deals grossing $2.6 billion, lower than Q1’s 182 deals at $3.7 billion. The medical device industry saw a […]
VC fund adds PricewaterhouseCoopers to $17m embezzlement suit against founder Burrill
The investors behind a venture capital fund added accounting firm PricewaterhouseCoopers to a lawsuit alleging that the fund’s founder, biotech notable Stephen Burrill, and other fund executives looted it for $17 million. The Burrill Life Sciences Capital Fund III 1st sued last July, accusing Burrill, longtime outside-counsel-turned-staff-counsel Victor Hebert and CFO Helena Sen of diverting the cash […]
VCs put more into medtech last year | Medtech funding for the week of January 19, 2015
Report: VCs put more into fewer medtech deals last year
Venture capitalists put more cash into fewer deals backing medical device companies last year, according to the MoneyTree report, meaning that the average deal value rose nearly 28% in 2014.
Shares soar for InVivo after spinal cord study update | Medtech Wall Street news for the week of November 17, 2014
MDT prepares $10B worth of bonds to help fund its $43B acquisition of COV | The week in medtech M&A
Venture capital investment in medtech grows in Q3
Venture capitalists put more cash into more deals for medical device companies during the 3rd quarter, according to a report from PricewaterhouseCoopers.
Medical device companies pulled down $586 million in 78 deals during the 3rd quarter, up 13% in dollars and 18% in deal volume compared with Q3 2013.
Medtech mergers stayed strong in Q3
The merger & acquisition frenzy that consumed the medical device industry during the 2nd quarter stayed strong during the ensuing period, although the value of the Q3 deals slipped a bit, according to PricewaterhouseCoopers.
- 1
- 2
- 3
- …
- 6
- Next Page »
